Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
BMC Infectious Diseases|November 18, 2017
Effectiveness of current and future regimens for treating genotype 3 hepatitis C virus infection: a large-scale systematic reviewHosnieh Fathi, Andrew Clark, Nathan R Hill, et al.Inhalation Toxicology|June 19, 2004
Long-term respiratory disorders of claimers with subclinical exposure to chemical warfare agentsMostafa Ghanei, Hosnieh Fathi, Mohammad Mir Mohammad, et al.Cough (London, England)|January 20, 2009
Cough in adult cystic fibrosis: diagnosis and response to fundoplicationHosnieh Fathi, Tanya Moon, Jo Donaldson, et al.Respirology (Carlton, Vic.)|June 29, 2011
Chronic cough and esomeprazole: a double-blind placebo-controlled parallel studyShoaib Faruqi, Ian D Molyneux, Hosnieh Fathi, et al.Journal of Gastroenterology and Hepatology|February 27, 2003
Lower esophagus in dyspeptic Iranian patients: a prospective studySiavosh Nasseri-Moghaddam, Reza Malekzadeh, Masoud Sotoudeh, et al.Plos One|January 14, 2016
Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge ModelDaniel J Fullen, Nicolas Noulin, Andrew Catchpole, et al.Plos One|June 10, 2016
Correction: Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge ModelDaniel J Fullen, Nicolas Noulin, Andrew Catchpole, et al.The New England Journal of Medicine|November 19, 2015
Activity of Oral ALS-008176 in a Respiratory Syncytial Virus Challenge StudyJohn P DeVincenzo, Matthew W McClure, Julian A Symons, et al.Antimicrobial Agents and Chemotherapy|August 16, 2017
Phase 2 Randomized Trial of the Safety and Efficacy of MHAA4549A, a Broadly Neutralizing Monoclonal Antibody, in a Human Influenza A Virus Challenge ModelJacqueline M McBride, Jeremy J Lim, Tracy Burgess, et al.Pageof 1